Embed Size (px)
Citation preview
Cancer ServicesNewsletter Autumn 2014
Welcome to the Autumn edition of the Cancer Services Newsletter
Inside this issue:
• New Lead Cancer Clinician • New partnership to improve cancer services • Blossom Appeal funds equipment
• HPB service transfers to MRI • Mayor’s visit to haematology services • Cancer peer review• Listening to Patients • View from the top • Group support for cancer patients• Look good, feel better coming to
Pennine • Welcome and Farewells • Trust’s Cancer Performance
• Macmillan Healthwatch Event • Cancer Team Contacts
New Lead Clinician for Cancer Services at the TrustDr Roger Prudham has been appointed as the Trust’s Lead Cancer Clinician. Deputy Medical Director (Quality) since 2013, he is also Caldicott Guardian for the Trust and chairs the clinical audit and effectiveness committee. Roger also works as a Consultant Gastroenterologist and is the Clinical Director of the Pennine Bowel Cancer Screening Programme. He has previously undertaken other Clinical Director roles, including gastroenterology, endoscopy and medicine. HehasalsoworkedastheClinicalAreaTeamleadforMedicineatFairfieldGeneralHospital.Of his role as Lead Cancer Clinician Roger said “It is an exciting time to be involved in cancer in Pennine and in Manchester with the inception of Manchester Cancer and new pathway boards. I have a deep conviction that we can help outcomes in the city match those in the rest of the country and subsequently the rest of Europe. This is a challenge that I relish and look forward to taking the team with me to achieve”.Born in Crumpsall, Roger considers himself to be an ‘all round Pennine type of person’ having been schooled in Oldham and starting his consultant career in Bury. He graduated from St Bartholomew’s in London in 1992 but chosetocomebackuptoManchestertodojuniordoctorjobs,thenstayedatHopehospitalasSeniorHouseOfficerand Registrar, with a brief stint on the transplant unit at St James’s Hospital in Leeds in between.As a consultant gastroenterologist, he has a particular interest in colonoscopy and set up the bowel cancer screening programme at Pennine in 2007 with an enormous amount of support and hard work from nursing, medical and managerial colleagues. He describes this experience as having helped him to cut his leadership teeth – “ To succeed the National programme has had to take a radical approach to quality assurance and is now, I believe, oneofthebestexamplesofaqualityassuredhealthcareinterventionontheworld.Ialsofirmlybelievethatwithsimilar commitment, leadership and team working form nursing, medical and managerial colleagues we can improve outcomes for cancer”.
Hepato-Pancreato-Biliary (HPB) service transfers to Manchester Royal InfirmaryOn 6th October the HPB surgical service provided at North Manchester General Hospital moved to Manchester Royal InfirmarytomergewiththeservicecurrentlyprovidedatCentralManchesterHospitalsNHSFoundationTrust(CMFT).The creation of a single specialist multi-disciplinary team (MDT) for patients across Greater Manchester and parts of Cheshire ensures centralisation and concentration of expertise, in line with best practice guidance.PatientswillstillhavethebenefitofclinicsanddiagnosticandtreatmentfacilitiesattheirlocalPennineAcuteNHSHospital. The existing 2 week wait referral pathway for patients with suspected cancer should still be used. Referrals received into Pennine Acute will be triaged by a gastroenterologist and directed as appropriate to urgent investigations and clinics in Pennine. Onward referral of patients to the specialist MDT will be arranged by Pennine Acute where required. The process for routine referrals previously sent to Pennine is unchanged. Referral to the service at CMFT will also be arranged by Pennine Acute for patients who need it.For more information please contact Amy Brierley ([email protected]) or Gillian Ivey ([email protected]).
Listening to PatientsHaving attended a presentation about Listening Into Action (LiA) Julie Williams and Julie Meadows, Colorectal and Stoma Care Specialist Nurses at the Trust, decided to try the approach, which until then had only been used to consult Trust staff, with patients. The two nurses who regularly attend theTrust’s colorectal/stoma support group wanted to consult members of the group who have had cancer, as a group of expert patients with a wealth of experience, to ask them for ideas to improve the colorectal/stoma service. The group meets every 3 months at The Victoria Hotel in Chadderton, attended by around 60 people including patients with a range of bowel conditions and their carers, and provided a way ofconnectingdirectlywithpatientstofindoutwhatmatterstothem.Althoughpatientsandcarersare often sent satisfaction surveys and feedback questionnaires these can be lengthy forms with low response rates, and there is often no opportunity to feed back about actions taken as a result. Consulting the group meant that feedback could also be provided about changes made in response to their comments. The LiA team was therefore invited to facilitate a 2 hour patient conversation, focusing on 3 questions:
- What do we get right? - What do we sometimes get wrong? - How can we improve our service?
The interactive, informal approach encourages attendees to discuss the questions in small groups around tables and then write down their comments on the paper tablecloth. Flip charts are also used to capture conversations. The approach generated a lot of discussion and plenty of suggestions and ideas to work on. Comments included:
“ My GP doesn’t know what I’ve had done”“ At our age we can’t remember date of last scan etc”
“I have to tell the GP what I need” Feedback was then collated and organised into themes, and included support for carers, conditions on the wards, stoma issues and hospital communication and record keeping. Particularly highlighted were the need for concise documentation in medical notes, and the need to improve communication between the hospital and the patient’s GP, as confusion arose between patients and health professionals.Feedback on the comments was provided at the next meeting, and the group was consulted about the use of a treatment summary to address the main issues they had raised. Treatment summaries are a key part of the National Cancer Survivorship Initiative’s recommendations to improve care for people living with and beyond cancer, by providing a concise summary of the patient’s diagnosis and treatment and on-going plan for management. This is then available to their GP, as well as secondary care, A&E staff, and the patients themselves. The group saw this as an excellent tool to aidcommunicationandidentifiedpracticalusesforthem,includinghelpingwithapplicationsfortravelinsurance, and to share with family members. All colorectal cancer patients will soon have a copy of their treatment summary given to them at theirfirstconsultationpostcancertreatment,withfurthercopiessenttotheGPandacopyatthefront of their medical notes. Julie Williams said of the experience “LiA has proved an excellent way of consulting members of the support group, listening to them, being able to acknowledge their concerns, and improving the things that matter to them, and I would strongly recommend it.”Participants provided positive feedback about the event, including valuing being listened to and being able to share their thoughts with like-minded people.For further details please contact [email protected], Macmillan Colorectal Nurse Specialist, [email protected]. Macmillan Stoma Care Nurse or [email protected], Listening into Action Lead
Macmillan Healthwatch Consultation EventMacmillan Cancer Support and Healthwatch are holding a ground breaking half day event to bring together people affected by cancer from across Greater Manchester.The aim of the event, which is open to people with experience of cancer (including family members, friends,
carers) is to provide background to how and why poor communication is an issue for the NHS and other services, and to obtain attendees’ experiences and views. This will then be used to galvanise changes required to improve communication and patient experience, both at local and Greater Manchester level.Anyone who would like to attend the event, which is being held on November 17th, 10.00 am to 1.00 pm, should ring 01904 756432 or email [email protected]
Look Good, Feel Better coming to Pennine
In conjunction with the Macmillan Information and Support Centre at North Manchester General Hospital, a programme of Look Good, Feel Better (LGFB) Masterclasses are being held for women who have been affected by any type of cancer.
LGFB is a charity which provides practical support for women struggling with side effects from cancer treatment.Itisdedicatedtoimprovingtheself-esteem,confidenceandwellbeingofpeopleundergoingtreatment for any sort of cancer.
The aim of the sessions is to improve participants’ self-image and appearance through free group and self-helpskincareandmake-upworkshopsthatcreateasenseofsupport,confidence,andwellbeing.Sessionsare held on a regular basis at Salford Royal Hospital and the main Christie site at Withington.
The LGFB Masterclass programme has been developed to maintainthekeybenefitsofLGFB’sworkinbringinggroupsof women and teenagers together in a relaxing and uplifting environment to teach them skincare and make-up skills to help combat the visible side effects of treatment. LGFB’s aim in introducing the Masterclass has been to give the charity far greaterflexibilityonwhenandwhereclassestakeplace.Heldin hospitals and cancer care centres throughout the UK, each Workshop (normally 10 -12 attendees) is run by a team of qualifiedbeautyvolunteers.Ourvolunteershaveawealthofexperience either working for many of our supporting cosmetic brands within department stores, or who work independently as freelance make-up artists, within salons or run their own beauty businesses.
In order to reach out to more women in areas across the country not currently covered, LGFB Masterclasses can be hosted as a one off or regular session held in a suitable private room anytime during the day/evening or even at weekends. Like the core LGFB Workshops, each free two hour LGFB Masterclass follows a set skincare and make-up programme and is open to women who have been affected by all types of cancer.
Sessions will be for 10-15 people and women attending are asked to bring their own kit of cosmetic products. Prior to the event a voucher for 25% off any make up purchased from Boots will be issued to women attending. LGFB will provide core skincare items and information about what participants need to bring to a class . LGFB’s team of volunteer beauty professionals not only provide tips on skincare and make-up techniques, but will be very happy to give guidance on make-up products taken to the class, advising what products and colours work best.
TofindoutmoreaboutthesessioncontacttheMacmillanInformationandSupportCentreatNorthManchester General Hospital on 0161 604 5244.
New partnership aims to improve cancer services and increase survival rates in Greater Manchester
Thanks to a new ground breaking partnership, people in Greater Manchester and East Cheshire aresettobenefitfromanintegratedcancersystemforthefirsttime.Despitehavinggreathospitals and a wealth of cancer research expertise, mortality rates from cancer in Greater Manchester remain stubbornly high with around 460 lives in the area lost prematurely each year because cancer survival rates are well below the national average: 27.2% of Greater Manchester’scancerpatientsarefirstdiagnosedfollowingatriptoA&E,comparedto24.7%inthe rest of England, a clear sign that opportunities to diagnose and treat cancer earlier are being missed.
Manchester Cancer seeks to address this by bringing together NHS services that treat people with cancer, research into the disease, and education of healthcare professionals, all vital components of integrated care. This partnership is led by doctors, nurses and other health professionalswhoarebeingencouragedtoworktogethertoovercomeartificialboundarieswithin the NHS and ensure that patients, and their families, receive the highest quality services.
Thomas Pharaoh, Associate Director of Manchester Cancer said “Our aim is to become one ofthetopfiveintegratedcancersystemsintheworld,securingworld-classoutcomesforthecancer patients and populations that we serve.” David Shackley, a cancer surgeon from Salford Royal is leading Manchester Cancer’s work to improve cancer services in NHS hospitals, alongside 20 senior doctors and nurses who each lead the improvement of services for a particular cancer type.
These clinical leaders are already bringing together their clinical colleagues from across the region to identify ways to make things better. All of the clinical groups are aiming to involve GPs and people affected by cancer in their work. David Shackley said: “The clinical groups are vital to the success of Manchester Cancer. We want them to have the power to bring about real change on the ground, so that we can continue to improve the experience that people have of their cancer care, and of course their outcomes from it.”
Manchester Cancer is unique in having the support of the whole healthcare community in GreatManchesterandEastCheshire,withthechiefexecutiveofficersofall10NHShospitaltrusts in Greater Manchester and East Cheshire playing a vital role in its creation and on-going development. It is also supported by the NHS commissioning groups in Greater Manchester and East Cheshire who now fund the majority of health care. Other NHS organisations and Manchester’s universities are also supporting the partnership, along with the city’s pioneering cancer research cluster (Manchester Cancer Research Centre) and organisations in the voluntary sector, such as Macmillan Cancer Support.
Nicola Cook, Senior Development Manager at Macmillan Cancer Support said: “Manchester Cancer provides a real opportunity for us all to work together to make genuine improvements for people affected by cancer across Greater Manchester and East Cheshire and Macmillan is very pleased to be a part of it.”
The 10 NHS Trusts involved in Manchester Cancer are Bolton NHS Foundation Trust, Central Manchester University Hospitals NHS Foundation Trust, East Cheshire NHS Trust,Pennine Acute Hospitals NHS Trust, Salford Royal NHS Foundation Trust, Stockport NHS Foundation Trust, Tameside Hospital NHS Foundation Trust, The Christie NHS Foundation Trust, University Hospital of South Manchester NHS Foundation Trust, Wrightington, Wigan and Leigh NHS Foundation Trust
Pennine Acute Hospitals is working closely with Manchester Cancer to improve outcomes for people with cancer, and has a range of professional groups represented on the clinical and cross-cutting groups.
For further information contact Thomas Pharaoh, Associate Director, [email protected] or go to manchestercancer.org.
Mayor of Oldham Visits Haematology Unit at Royal Oldham HospitalThe Mayor and Mayoress of Oldham, Coucillor Fida Hussain and Tanvir Hussain, visited ward F11 at The Royal Oldham Hospital as part of the Mayor’s annual tour of the hospital.The ward, which opened in June 2010, provides both in-patient and day case care for both malignant and non-malignant haematology patients.The 22 bedded in-patient ward, which is open seven days a week, and the attached day unit which is open Monday to Friday 8.00 am to 6.00 pm, delivers a variety of treatments including intensive intravenous chemotherapy and supportive therapies such as blood transfusion, antibiotics and intravenous iron.Haematology matron Sr Elizabeth Fitton said: “We enjoyed welcoming the Mayor and Mayoress to our unit. They both
seemedinterestedintheworkontheunitastheytouredthe11siderooms,fiveofwhichhaveaspecialisedairflowsystem(hepafilteredrooms)whichhelpstoprotectspatientsfrominfections.”The unit has approximately 70 admissions per month and sees around 1,000 patients per month in the day case unit.Patient John Duffy is pictured with The Mayor and Mayoress of Oldham, Councillor Fida Hussain and Tanvir Hussain.
View from the top – the new Trust’s Chief Executive Visits to Cancer Services
SincejoiningtheTrustasChiefExecutiveinApril2014DrGillianFairfieldhasbeenoutandaboutspendingtimeindifferentareasoftheTrusttofindoutmoreabouttheservicesitprovides.Thishas included time spent with a member of the Acute Oncology Team, and at the Victoria Suite and haematology unit at Oldham.
AfteramorningspentshadowingTracyWild,MacmillanAcuteOncologyNurseDrFairfieldrecognisedthe Acute Oncology Team as a tremendous resource which is really valued and highly praised by allwhousetheservice.ShesawatfirsthandhowTracyrespondstorequeststoseepatientsandsmooth their journey through admission, supporting them and using her expertise to improve their care, saying “Tracy makes sure all members of the team know about the plan of care to ensure a seamless service. But it was actually seeing Tracy in action on a face to face basis with her patients that was very impressive. I sat in on a consultation with a gentleman who had been admitted suffering greatly with side effects post chemotherapy. It was a very emotional consultation for the patient concerned and as I observed the conversation it suddenly hit me that, there right in front of me, was the complete demonstration of our Trust values in one nurse. Every kind word, every touch of the hand, the calmness and reassuring manner, the obvious knowledge and skill combined with a genuine compassion and desire to do the best for the patient made this a very humbling experience to be part of. Well done Tracy, your patients are extremely fortunate to have you looking after them and we are very lucky to have you as one of our staff”.
DrFairfielddescribedhervisittotheVictoriaBreastUnitatOldhamas“afantasticexperiencetoseehow the service works and how the service smooths the diagnosis and assessment period to make it as stress-free as possible”.
The haematology unit at ROH was also praised.” What struck me about this unit is that staff not only provide a high standard of care but so importantly they provide support and hope. Sadly not all patients can have a happy outcome but as one patient told me ‘while I have lost my battle with leukaemia the staff have been with me all the way and for that I am immensely grateful’. Another patient told me ‘I am always a person here and not a number. Nothing is too much trouble’.
DrFairfieldthankedeveryoneconcernedforeverythingtheydo,anddescribedhowhervisitshadmade her proud to be part of the Trust.
Hello…… and FarewellsThe Trust would like to welcome Liz Eccleston to her new post as member of the Macmillan Acute Oncology Service. Liz was previously ward manager on ward J5 at North Manchester General Hospital, and also Ann-Marie Francis who has joined the Trust as Interim Lead Cancer Manager.
Sally Lees has joined the Palliative Care Team at The Royal Oldham Hospital on secondment and Maureen Goulden has taken up a secondment as Palliative Care Educator at Oldham (hospital and community).Best wishes to all members of the Hepato-Pancreato-Biliary (HPB) service who have left the Trust with the transfer of the service to Central Manchester, and to Mr Gupta and Mr Chow, consultant urology surgeons, have both recently retired from the Trust.
Blossom Appeal Funds Deep Oscillation Therapy for Breast Cancer Patients
Local breast cancer charity the Blossom Appeal has funded a new piece of high tech equipment which will dramatically reduce the levels of pain and discomfort experienced by sufferers of lymphoedema and breast oedema, both common side effects for breast cancer.Lymphoedema is a chronic swelling of a part of the body, dueprimarilytowastefluidfailingtodrainthroughthelymphatic system correctly. It usually affects the arm but can also affect the breast itself. Patients suffer from heavy aching limbs, repeated skin infections, painful joints, hyper sensitivity and reduced mobility.The charity has paid for a Hivama machine, the latest in deep oscillation therapy, which uses electrostatic attraction and friction to produce vibrations deep into body tissues.The therapy will be available for all patients living in the Pennine Trust catchment area, including the breast care units at North Manchester General Hospital and the Royal Oldham Hospital.Helen Readdie, Lymphoedema Clinical Nurse Specialist at Royal Oldham Hospital, shown above with the Hivama machine, explains: “Instead of having to endure a very deep, painful massage to break up the hardened tissue, patients having deep oscillation therapy receive a relaxing
treatment where vibrations permeate 8cm under the skin to produce the same effects - without the pain. “It has been clinically proven to be highly effective in reducing the swelling and pain associated with lymphodoemaandreducingfibrosisandcandoubletheresultsoftraditionalManualLymphaticDrainage techniques.”The therapy will be available for all patients living in the Pennine Trust catchment area, including the breast care units at North Manchester General Hospital and the Royal Oldham Hospital.The Blossom Appeal helps to provide better facilities for patients and new equipment that the NHS cannot afford. Charity Treasurer and Macmillan Breast Care Nurse Specialist at North Manchester General Hospital, Frances Rosenberg added: “We already fund complementary therapy sessions like aromatherapy massages and acupuncture for patients but we’re delighted to be able to fund this equipment. Our aim is to make the patient’s journey that bit easier, and with NHS budgets under such scrutiny currently, this is exactly the sort of treatment which is not widely available on the health service but which can make a big difference to a patient’s quality of life.”
For more information about the Blossom Appeal go to www.blossomappeal.org.
Do you have patients living with and beyond cancer?Let them know about our friendly support group
“It’s a morale boost. You recognise that you have moved forward.” “It’s good to share and reflect with other people. You learn new things.”
“I realise I’m not alone with cancer and can draw inspiration from others in the group.” The Living With and Beyond Cancer support group meets monthly at the Post-Graduate Centre, North Manchester General Hospital. Group members have had cancer or are living with the condition. Each month there is an informal discussion around a different theme, facilitated by a Macmillan Professional:
Healthy eating - With Liz McCreery, Macmillan DietitianThursday 6th November, 10am – 12 noon
The effect of cancer on loved ones - session open to patients, their partners, family and friends Thursday 4th December, 10am – 12 noon
New members are always welcome. If any of your patients are interested, please ask them to contact AliDavenport,MacmillanCommunityOutreachOfficer:2273727or07767663099,[email protected] - or call Ali to make a referral. The group is partnership activity between the Macmillan Information & Support Services in Manchester City Council and the Macmillan Information and Support Centre at North Manchester General Hospital.
Cancer Peer Review 2014The National Cancer Peer Review Programme (NPRP) is a quality assurance programme that is aimed at reviewing clinical teams and services to determine their compliance against national measures, as well as the assessment of quality aspects of clinical care and treatment. The NCPRP encompasses a whole systems approach to quality and safety in relation to patient experience and clinical outcomes and aims to improve care for people affected by cancer by
• ensuring services are as safe as possible • improving the quality and effectiveness of care • improving the patient and carer experience • undertaking independent, fair reviews of services • providing development and learning for all involved • encouraging the dissemination of good practice.
The Trust’s Cancer Team, clinicians and other multi-disciplinary team (MDT) members, with the support of patient users, senior managers from the Trust and representatives from local Clinical Commissioning Groups, undergo review by validated self –assessment panels (previously known as internal validation). This is undertaken for all cancer MDTs and services (including Chemotherapy & Acute Oncology) and measures compliance against measures outlined in the section of the Manual of Cancer Standards relevant to the team being assessed. The process includes a panel discussion with key MDT members to assess the MDT’s compliance supported by 4 key documents: the MDT’s Operational Policy, Annual Report, Work Programme and Lead Clinician’s Self-Assessment Report. In addition this year the Clinical Nurse Specialist Services’ Annual Reports were included too where available.The 2014 cycle of peer review assessments has been completed. Reports of the outcome of the process are made available on the CQuins website (www.cquins.nhs.uk), as well as on the ‘My Cancer Treatment’ website (www.mycancertreatment.nhs.uk). Both sites are accessible to patients and the public. Further information about peer review is available from Catherine Sharp, Cancer Quality Co-ordinator on 0161 627 8424 (78424 internal) or Alison McCarthy, Macmillan Lead Cancer & Palliative Care Nurse on 0161 627 8699 (78699 internal).
Cancer PerformanceGetting cancer diagnosed as early as possible and starting treatment quickly are key to improving survival for many cancers. Meeting national targets introduced to ensure timely diagnosis and treatment for patients with cancer can at times represent a challenge, for many different reasons. The Trust met all itstargetsforthefirst3quartersof2013/14,butfailed2oftheminthelastquarter,asshowninthetable
Failure to meet the target for symptomatic breast patients was due to capacity issues and because of much higher number of referrals. The screening target was breached because 3 patients did not start their treatment within the required time frame, mainly due to patient choice. There continues to be a steady increase in the numbers of patients referred urgently by their GP with suspected cancer. There was also a considerable increase in the number of patients diagnosed with cancer. The increasing levels of activity and complexity of presenting patients continues to present a challenge to the Trust which is working hard to ensure that breaches are kept to a minimum. It has also achieved the target related to onward referral to tertiary centres within 42 days to ensure that the tertiary centre is able to assess and treat patients within the 62 day target.
Getting in printIf you have something you would like to share
please contact:Felicity Keeling on 0161-604-5244 (Internal 45244)
or e-mail [email protected].
Cancer Team Contacts (internal numbers in brackets)
Roger Prudham, Lead Cancer Clinician 0161 604 5461 (45461)
Jo Keogh, Associate Director, Elective Access (Strategic Lead for Cancer)
01706 517891 (57891)
Anne-Marie Francis, Interim Lead Cancer Manager
01706 906687 (56687)
Alison McCarthy, Macmillan Lead Cancer and Palliative Care Nurse 0161 627 8699
(78699)Alice Davies, Macmillan Associate Lead Cancer and Palliative Care NurseCatherine Sharp, Cancer Quality Co-ordinator
0161 627 8424 (78424)
Lindsey Newton, Macmillan Lead Chemotherapy Nurse
0161 778 5599 (75599)
Felicity Keeling, Macmillan Information Service Manager
0161 604 5244 (45244)
Heather Kilpatrick, Cancer Tracker Supervisor
01706 906535 (56535)
William Wood, Acting Performance & Compliance Manager
01706 906660 (56660)
Cancer Performance Getting cancer diagnosed as early as possible and starting treatment quickly are key to improving survival for many cancers. Meeting national targets introduced to ensure timely diagnosis and treatment for patients with cancer can at times represent a challenge, for many different reasons. The Trust met all its targets for the first 3 quarters of 2013/14, as shown in the table below: Target National
Standard Q1
13/14 No of
patients Q2
13/14 No of
patients Q3
13/14 No of
patients Patients seen within 2 weeks of GP referring as suspected cancer
93% 98 3474 97.4 3662 95.8 3733
Patients with any breast symptoms seen within 2 weeks of GP referral
93% 97.3 660 94.6 610 94.3 627
Patients starting first treatment within 31 days of the treatment decision
96% 99.4 480 100 537 99.6 515
Patients starting subsequent drug treatment within 31 days of the decision about that treatment
98% 100 78 100 150 98.3 60
Patients having subsequent surgical treatment within 31 days of the decision about that treatment
94% 100 86 100 85 98.7 79
Patients with a confirmed cancer diagnosis starting first treatment with 62 days of urgent suspected cancer GP referral
85% 90.9 241 91.6 327.5 89.3 319
Patients starting treatment within 62 days after urgent referral as a result of attending screening (breast, bowel or cervical)
90% 92.9 7 96.7 15 97.1 17
Patients starting treatment within 62 days after non-‐urgent referral by GP when referral has been upgraded to suspected cancer by their consultant
N/A 92 45 92.6 54 93.1 65
Source: Cancer Waiting Times Database / Somerset Cancer Register
In the 3 quarters reported, all targets were met despite a steady increase in the numbers of patients referred urgently by their GP with suspected cancer. There was also a considerable increase in the number of patients diagnosed with cancer and receiving their first treatment within 62 days of referral. Whilst meeting all its targets, the actual number of breaches increased, which is likely to be due to the increasing levels of activity and complexity of presenting patients. The Trust is working hard to ensure that breaches are kept to a minimum. It has also achieved the target related to onward referral to tertiary centres within 42 days to ensure that the tertiary centre is able to assess and treat patients within the 62 day target.
Target National Standard
Q1 13/14
Total patients
Q2 13/14
Total patients
Q3 13/14
Total patients
Q4 13/14
Total patients
Patients seen within 2 weeks of GP referring as suspected cancer 93% 98 3474 97.4 3662 95.8 3733 96.1 4008
Patients with any breast symptoms seen within 2 weeks of GP referral 93% 97.3 660 94.6 610 94.3 627 89.4 710
Patientsstartingfirsttreatmentwithin31days of the treatment decision 96% 99.4 480 100 537 99.6 515 99.5 442
Patients starting subsequent drug treatment within 31 days of the decision about that treatment
98% 100 78 100 150 98.3 60 100 62
Patients having subsequent surgical treatment within 31 days of the decision about that treatment
94% 100 86 100 85 98.7 79 100 72
Patientswithaconfirmedcancerdiagnosisstartingfirsttreatmentwith62daysofurgent suspected cancer GP referral
85% 90.9 241 91.6 327.5 89.3 319 85.6 285.5
Patients starting treatment within 62 days after urgent referral as a result of attending screening (breast, bowel or cervical)
90% 92.9 7 96.7 15 97.1 17 84 12.5
Patients starting treatment within 62 days after non-urgent referral by GP when referral has been upgraded to suspected cancer by their consultant
N/A 92 45 92.6 54 93.1 65 87.9 66
